Editors, P. O. Editorial Note: Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1-7). Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationEditors, PLOS ONE. Editorial Note: Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1-7). Public Library of Science (PLoS).
MLA (9th ed.) CitationEditors, PLOS ONE. Editorial Note: Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1-7). Public Library of Science (PLoS).
Warning: These citations may not always be 100% accurate.